Procept Biorobotics Corp (PRCT)

$52.07 +1.34 (2.64%)
Market Cap 2.78B
Revenue (ttm) 224.50M
Net Income (ttm) -91.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -40.72%
Debt to Equity Ratio 0.13
Volume 657,700
Avg Vol 969,244
Day's Range N/A - N/A
Shares Out 54.82M
Stochastic %K 43%
Beta 1.09
Analysts Strong Sell
Price Target $94.25

Latest News on PRCT

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas

Apr 10, 2025, 4:03 PM EDT - 1 day ago

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas

WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation

Mar 24, 2025, 8:00 AM EDT - 18 days ago

WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada

Mar 14, 2025, 8:00 AM EDT - 4 weeks ago

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada

Procept BioRobotics: Strong Growth, But Profitability Seems Far Away

Mar 11, 2025, 4:42 AM EDT - 4 weeks ago

Procept BioRobotics: Strong Growth, But Profitability Seems Far Away

PROCEPT BioRobotics® Reports Fourth Quarter and Full Year 2024 Results

Feb 25, 2025, 4:02 PM EST - 6 weeks ago

PROCEPT BioRobotics® Reports Fourth Quarter and Full Year 2024 Results

PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference

Feb 7, 2025, 8:00 AM EST - 2 months ago

PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference

Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on PROCEPT BioRobotics (NASDAQ: PRCT)

Jan 16, 2025, 9:00 AM EST - 3 months ago

Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on PROCEPT BioRobotics (NASDAQ: PRCT)

PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024

Nov 26, 2024, 4:05 PM EST - 4 months ago

PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024

Procept BioRobotics: Continued Growth Runway Ahead

Nov 26, 2024, 5:10 AM EST - 4 months ago

Procept BioRobotics: Continued Growth Runway Ahead

PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock

Oct 29, 2024, 8:43 PM EDT - 5 months ago

PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock

PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock

Oct 28, 2024, 4:19 PM EDT - 5 months ago

PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock

Surgical Robotics Provider PROCEPT BioRobotics' Q3 Earnings Beats Street View, Analyst Optimistic About Upside Potential

Oct 28, 2024, 2:17 PM EDT - 5 months ago

Surgical Robotics Provider PROCEPT BioRobotics' Q3 Earnings Beats Street View, Analyst Optimistic About Upside Potential

PROCEPT BioRobotics Corporation (PRCT) Q3 2024 Earnings Call Transcript

Oct 28, 2024, 10:32 AM EDT - 5 months ago

PROCEPT BioRobotics Corporation (PRCT) Q3 2024 Earnings Call Transcript

PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance

Oct 28, 2024, 7:00 AM EDT - 5 months ago

PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance

PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024

Oct 9, 2024, 4:04 PM EDT - 6 months ago

PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024

PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer

Oct 7, 2024, 4:04 PM EDT - 6 months ago

PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer

PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024

Aug 28, 2024, 4:03 PM EDT - 8 months ago

PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024

Procept BioRobotics: Risk Capital Unlock With FDA Hydros Approval

Aug 27, 2024, 8:30 AM EDT - 8 months ago

Procept BioRobotics: Risk Capital Unlock With FDA Hydros Approval

PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy

Aug 21, 2024, 7:00 AM EDT - 8 months ago

PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy

PROCEPT BioRobotics Corporation (PRCT) Q2 2024 Earnings Call Transcript

Aug 3, 2024, 9:23 PM EDT - 8 months ago

PROCEPT BioRobotics Corporation (PRCT) Q2 2024 Earnings Call Transcript

PROCEPT BioRobotics® Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue and EBITDA Guidance

Aug 1, 2024, 4:03 PM EDT - 9 months ago

PROCEPT BioRobotics® Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue and EBITDA Guidance

PROCEPT BioRobotics to Report Second Quarter 2024 Financial Results on August 1, 2024

Jul 15, 2024, 4:03 PM EDT - 9 months ago

PROCEPT BioRobotics to Report Second Quarter 2024 Financial Results on August 1, 2024

PROCEPT BioRobotics Announces New CPT® Category I Code from the American Medical Association for Aquablation therapy

Jun 17, 2024, 4:03 PM EDT - 10 months ago

PROCEPT BioRobotics Announces New CPT® Category I Code from the American Medical Association for Aquablation therapy

PROCEPT BioRobotics to Present at Upcoming 2024 Truist Securities MedTech Conference on June 18, 2024

Jun 3, 2024, 4:03 PM EDT - 11 months ago

PROCEPT BioRobotics to Present at Upcoming 2024 Truist Securities MedTech Conference on June 18, 2024

PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference

May 13, 2024, 4:05 PM EDT - 11 months ago

PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference

Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia

May 6, 2024, 8:00 AM EDT - 1 year ago

Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia

PROCEPT BioRobotics Corporation (PRCT) Q1 2024 Earnings Call Transcript

May 1, 2024, 12:56 PM EDT - 1 year ago

PROCEPT BioRobotics Corporation (PRCT) Q1 2024 Earnings Call Transcript

PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

May 1, 2024, 7:00 AM EDT - 1 year ago

PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting

Apr 23, 2024, 8:00 AM EDT - 1 year ago

PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting

PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas

Apr 4, 2024, 4:04 PM EDT - 1 year ago

PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas

PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024

Apr 2, 2024, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024

PROCEPT BioRobotics Corporation (PRCT) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 12:09 AM EST - 1 year ago

PROCEPT BioRobotics Corporation (PRCT) Q4 2023 Earnings Call Transcript

PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2023 Results

Feb 27, 2024, 4:02 PM EST - 1 year ago

PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2023 Results

PROCEPT BioRobotics to Present at the 44th Annual TD Cowen Health Care Conference in Boston

Feb 12, 2024, 4:05 PM EST - 1 year ago

PROCEPT BioRobotics to Present at the 44th Annual TD Cowen Health Care Conference in Boston

PROCEPT BioRobotics® Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million

Jan 8, 2024, 5:00 PM EST - 1 year ago

PROCEPT BioRobotics® Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million

PROCEPT BioRobotics to Present at the 35ᵗʰ Annual Piper Sandler Healthcare Conference in New York City

Nov 13, 2023, 4:03 PM EST - 1 year ago

PROCEPT BioRobotics to Present at the 35ᵗʰ Annual Piper Sandler Healthcare Conference in New York City

PROCEPT BioRobotics Corporation (PRCT) Q3 2023 Earnings Call Transcript

Nov 2, 2023, 12:01 AM EDT - 1 year ago

PROCEPT BioRobotics Corporation (PRCT) Q3 2023 Earnings Call Transcript

PROCEPT BioRobotics® Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance

Nov 1, 2023, 4:02 PM EDT - 1 year ago

PROCEPT BioRobotics® Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance

PROCEPT BioRobotics to Report Third Quarter 2023 Financial Results on November 1, 2023

Oct 16, 2023, 4:05 PM EDT - 1 year ago

PROCEPT BioRobotics to Report Third Quarter 2023 Financial Results on November 1, 2023

PROCEPT BioRobotics® Announces First Commercial Aquablation Therapy Procedures in Japan

Aug 22, 2023, 8:00 AM EDT - 1 year ago

PROCEPT BioRobotics® Announces First Commercial Aquablation Therapy Procedures in Japan

PROCEPT BioRobotics to Present at the 2023 Wells Fargo Healthcare Conference in Boston

Aug 17, 2023, 4:05 PM EDT - 1 year ago

PROCEPT BioRobotics to Present at the 2023 Wells Fargo Healthcare Conference in Boston

Procept BioRobotics: Adding Value Through Robust Unit Economics, Reiterate Buy

Aug 10, 2023, 3:24 PM EDT - 1 year ago

Procept BioRobotics: Adding Value Through Robust Unit Economics, Reiterate Buy

PROCEPT BioRobotics Corporation Announces Pricing of Upsized Offering of Common Stock

Aug 1, 2023, 10:10 PM EDT - 1 year ago

PROCEPT BioRobotics Corporation Announces Pricing of Upsized Offering of Common Stock

PROCEPT BioRobotics Corporation (PRCT) Q2 2023 Earnings Call Transcript

Jul 28, 2023, 5:23 PM EDT - 1 year ago

PROCEPT BioRobotics Corporation (PRCT) Q2 2023 Earnings Call Transcript

PROCEPT BioRobotics® Reports Second Quarter 2023 Financial Results and Increases 2023 Revenue Guidance

Jul 27, 2023, 7:00 AM EDT - 1 year ago

PROCEPT BioRobotics® Reports Second Quarter 2023 Financial Results and Increases 2023 Revenue Guidance

PROCEPT BioRobotics to Report Second Quarter 2023 Financial Results on July 27, 2023

Jul 11, 2023, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics to Report Second Quarter 2023 Financial Results on July 27, 2023

Procept BioRobotics: Adding For 2023 Rebound

May 30, 2023, 10:19 AM EDT - 2 years ago

Procept BioRobotics: Adding For 2023 Rebound

ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against PROCEPT BioRobotics Corporation and Encourages Investors with Losses to Contact the Firm

May 25, 2023, 11:45 PM EDT - 2 years ago

ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against PROCEPT BioRobotics Corporation and Encourages Investors with Losses to Contact the Firm

INVESTIGATION ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against PROCEPT BioRobotics Corporation and Encourages Investors with Losses to Contact the Firm

May 24, 2023, 10:20 PM EDT - 2 years ago

INVESTIGATION ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against PROCEPT BioRobotics Corporation and Encourages Investors with Losses to Contact the Firm